What is the catalog number for CD82 Rabbit Polyclonal Antibody?

The catalog number for CD82 Rabbit Polyclonal Antibody is orb215924.

What sizes are available for CD82 Rabbit Polyclonal Antibody?

CD82 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is CD82 Rabbit Polyclonal Antibody in stock?

CD82 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

CD82 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

CD82 antigen; C33 antigen; IA4; Inducible membrane protein R2; Metastasis suppressor Kangai-1; Suppressor of tumorigenicity 6 protein; Tetraspanin-27; Tspan-27; CD82; CD82; KAI1, SAR2, ST6, TSPAN27

UniProt

P27701

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human CD82 recombinant protein (Position: A98-Y267) . Human CD82 shares 69% and 67% amino acid (aa) sequences identity with mouse and rat CD82, respectively.

Target

CD82 antigen

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Disease Biomarkers, Epigenetics & Chromatin, Hematology, Immunology & Inflammation

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 2-5μg/ml, Human Western blot, 0.1-0.5μg/ml, Human

Form

Lyophilized

Molecular Weight

30-36 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.